Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2901e694724c2a759f619944cb7d2a4 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D453-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14 |
filingDate |
2002-03-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2005-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7963a2e88f9cdcd48c2d17f56601ba0c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af79073b098f1eaeaf52e483dac96ea8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86cbb300ce600d88a322eff6b183bf4b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0a16d0510e4b35e0bf040814ae6e48d4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f909ad95eb7c38bb9f09762e7054d7b8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16e2dc3616df030ce48a171d0c6c3dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9424eee43f8075bacd085b3efac8c453 |
publicationDate |
2005-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-6887873-B2 |
titleOfInvention |
Triazine derivatives and their application as antitelomerase agents |
abstract |
The present invention relates to cancer therapy and to novel anticancer agents having a mechanism of action which is quite specific. It also relates to novel chemical compounds as well as their therapeutic application in humans. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004167132-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9155753-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007232572-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004053966-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2011230489-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8796449-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010104586-A1 |
priorityDate |
2001-03-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |